Follow-The-Filings

DMAC · Diamedica Therapeutics Inc.

Q1 2021 13F holders

← latest ownership dossier

Ticker
DMAC
Type
Equity
Class
COM NEW
Total reported value ($000, long equity)
Manager Report date Value Shares